We found that the combination of preoperative serum cancer antigen 125 (CA125) level and molecular parameters with Mayo criteria improved the prognostic accuracy of lymph node metastasis risk in patients with high-risk EEC per Mayo criteria. Here, MUC16 is linked to metastatic malignant neoplasm in the lymph nodes.